走向个性化医疗方法:结合组织疾病的创新治疗方式
Charlene Redhead1, Nandaraj Taye1, Dirk Hubmacher1
1Orthopedic Research Laboratories, Leni & Peter W. May Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
新的分子疗法为治疗由细胞外矩阵 (ECM) 基因突变引起的结合组织疾病提供了希望. 这些方法旨在纠正突变,从而有可能治愈以前无法治疗的疾病.
科学领域:
- 遗传学和分子生物学
- 生物化学 生物化学
- 发展生物学 发展生物学
背景情况:
- 结缔组织疾病源于编码细胞外基因矩阵 (ECM) 蛋白质的基因突变.
- 这些疾病导致显著的发病率和死亡率,通常在发育或生长过程中表现出来.
- 成熟连接组织的有限再生能力阻碍了有效的治疗开发.
研究的目的:
- 审查结合组织疾病的创新治疗方式.
- 突出个性化医疗方法对这些疾病的潜力.
- 强调了解ECM调节和突变影响的必要性.
主要方法:
- 审查最近在整个外体序列测序和疾病建模方面的进展.
- 对突变特异性分子治疗方式的分析.
- 探索基因替代,外跳转,DNA/mRNA编辑和药理学策略.
主要成果:
- 技术的进步使得直接纠正致病突变成为可能.
- 在内源性组织改造阶段可以启动治疗策略.
- 对以前无法治愈的结缔组织疾病的治疗性个性化药物的潜力.
结论:
- 基因编辑和基因替代等创新疗法对结合组织疾病有很大的前景.
- 在关键发育窗口期间准ECM蛋白质突变至关重要.
- 对ECM平衡和突变特异性机制的进一步研究对于治疗成功至关重要.
更多相关视频
10:30Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
Published on: December 8, 2016
08:32Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms
Published on: March 22, 2024
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Tissue Renewal without Stem Cells
However, failure of such a system...
Clinical Applications of Epidermal Stem Cells
Tumor Immunotherapy
